AuraSense Therapeutics (AST) is a biopharmaceutical company developing first-in-class therapies based upon its proprietary Spherical Nucleic Acid (SNA„˘) gene regulation and immune modulation strategies. AST is leading the translation of SNA constructs as innovative medicines with a core focus on debilitating diseases with limited or no treatment options. AuraSense Therapeutics' uniquely engineered SNA„˘ constructs possess attractive biocompatibility and versatility as therapeutics and hold great promise for combating the most life-threatening diseases, including many forms of cancer, infectious disease, and skin conditions.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/18/14 | $13,600,000 | Series C |
Bill Gates Boon Hwee Koh Craig Mundie David Walt Patrick Ryan Rathmann Family Foundation | undisclosed |
